322 related articles for article (PubMed ID: 30041559)
1. Outcome of Direct Oral Anticoagulant Treatment for Acute Lower Limb Deep Venous Thrombosis After Total Knee Arthroplasty Or Total Hip Arthroplasty.
Mochizuki T; Ikari K; Yano K; Hiroshima R; Ishibashi M; Okazaki K
Mod Rheumatol; 2019 Jul; 29(4):682-686. PubMed ID: 30041559
[No Abstract] [Full Text] [Related]
2. A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery.
Mayer A; Schuster P; Fink B
Arch Orthop Trauma Surg; 2017 Jun; 137(6):797-803. PubMed ID: 28439702
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin time-international normalized ratio is a useful marker for edoxaban efficacy in preventing venous thromboembolism after total knee arthroplasty.
Kodato K; Ishida K; Shibanuma N; Toda A; Takayama K; Oka S; Hayashi S; Hashimoto S; Kurosaka M; Kuroda R; Matsumoto T
Eur J Orthop Surg Traumatol; 2018 Jan; 28(1):103-108. PubMed ID: 28766070
[TBL] [Abstract][Full Text] [Related]
4. Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty.
Russell RD; Huo MH
J Arthroplasty; 2013 Oct; 28(9):1477-81. PubMed ID: 23540535
[TBL] [Abstract][Full Text] [Related]
5. Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis.
King DA; Pow RE; Dickison DM; Vale PR
Intern Med J; 2016 Sep; 46(9):1030-7. PubMed ID: 27246450
[TBL] [Abstract][Full Text] [Related]
6. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI
Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized comparative study to determine appropriate edoxaban administration period, to prevent deep vein thromboembolism in patients with total knee arthroplasty.
Ishida K; Shibanuma N; Kodato K; Toda A; Sasaki H; Takayama K; Hayashi S; Hashimoto S; Matsushita T; Niikura T; Kurosaka M; Kuroda R; Matsumoto T
J Orthop Sci; 2018 Nov; 23(6):1005-1010. PubMed ID: 30431004
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial.
Fuji T; Wang CJ; Fujita S; Kawai Y; Nakamura M; Kimura T; Ibusuki K; Ushida H; Abe K; Tachibana S
Thromb Res; 2014 Dec; 134(6):1198-204. PubMed ID: 25294589
[TBL] [Abstract][Full Text] [Related]
9. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of edoxaban, an oral factor xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and Taiwan.
Fuji T; Wang CJ; Fujita S; Kawai Y; Kimura T; Tachibana S
J Arthroplasty; 2014 Dec; 29(12):2439-46. PubMed ID: 25047458
[TBL] [Abstract][Full Text] [Related]
11. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
Squizzato A; Lussana F; Cattaneo M
Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
[TBL] [Abstract][Full Text] [Related]
12. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
Cohen AT; Hamilton M; Mitchell SA; Phatak H; Liu X; Bird A; Tushabe D; Batson S
PLoS One; 2015; 10(12):e0144856. PubMed ID: 26716830
[TBL] [Abstract][Full Text] [Related]
14. A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty.
Fuji T; Fujita S; Tachibana S; Kawai Y
J Thromb Haemost; 2010 Nov; 8(11):2458-68. PubMed ID: 20723033
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulants: What is new and what is the standard?
Lesko LJ
Clin Pharmacol Ther; 2016 Aug; 100(2):126-8. PubMed ID: 27197625
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
Weitz JI; Segers A; Raskob G; Roberts RS; Francis C; Lassen MR; Fuji T; Swaim RM; Lee M; Peters G; DiBattiste PM; Tesfaye F; Strony J
J Thromb Haemost; 2019 Dec; 17(12):2081-2088. PubMed ID: 31529590
[TBL] [Abstract][Full Text] [Related]
18. Direct oral anticoagulants: An update.
Franco Moreno AI; Martín Díaz RM; García Navarro MJ
Med Clin (Barc); 2018 Sep; 151(5):198-206. PubMed ID: 29295790
[TBL] [Abstract][Full Text] [Related]
19. Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacement.
Lassen MR
Drugs Today (Barc); 2012 Apr; 48(4):249-58. PubMed ID: 22536567
[TBL] [Abstract][Full Text] [Related]
20. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
